ViAqua Therapeutics was established in September 2014 to address the growing need for effective, affordable health management of diseases in aquaculture. To date, ViAqua has received investments from The Trendlines Group , Nutreco, VisVires New Protein and the Technion–Israel Institute of Technology, with support from the Israel Innovation Authority.
Southwest Atlantic Squid Index: Illex Squid (Illex Argentinus) China
In order to continuously enhance the ability to control squid resources and price influence, and conduct more accurate resource assessment and forecasting, the China Ocean Fisheries Association&n...
Fishing Exports Increased by 10.4% in Q1 Argentina
This increase can be largely explained by the significant increase in squid sales compared to the same period last year, something that could change starting in April due to high competition from the ...